MassDevice.com +5 | The top 5 medtech stories for May 18, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters. 5. Medtronic owes spine doc inventor $24m for patent infringement Medtronic must fork over nearly $24 million to the physician inventor behind a group of patents covering a technique for treating spine defects. Dr. Mark Barry sued Medtronic in February 2014 in the U.S. District Court for Eastern Texas, alleging infringement for 3 patents covering a “system and method for aligning vertebrae in the amelioration of aberrant spinal column deviation conditions.” Read more 4. FDA panel recommends approval TransMedics lung transplant device An FDA advisory panel yesterday recommended that the federal safety watchdog approve a device made by TransMedics to keep donated lungs perfused during transport to transplantation procedures. The FDA’s Gastroenterology &Urology Devices panel voted 11-2 that the OCS Lung system is safe; 8-5 that it’s effective; and 9-4 that its benefits outweigh the risks, an FDA spokeswoman told MassDevice.com via email. Read more 3. EuroPCR Roundup: Medtronic’s Resolute Onyx meets primary endpoint in small-vessel trial ...
Epidural analgesia improves pain control and outcomes of abdominal aortic aneurysm procedures, while the effect of thoracic epidural analgesia on thoraco-abdominal aortic aneurysm (TAAA) repair is unknown. The aim of the study was to evaluate thoracic epidural analgesia effects in patients undergoing open TAAA repair in terms of pain control and clinically relevant outcomes.
This study compared the outcomes of open one stage with open two stage repair of type II thoraco-abdominal aortic aneurysms (TAAA).
A retrospective review of the National Health Service Abdominal Aortic Aneurysm Screening Programme was conducted in men older than 65 years in England between 2009 and 2017.
Fenestrated/branched endografts (FB-EVAR) are valid options to treat thoraco-abdominal aortic aneurysms (TAAA). Successful repair requires target-visceral-vessels (TVV) manipulation with possible splanchnic ischemia. Aim of the study was to evaluate the clinical impact of splanchnic ischemia occurring in FB-EVAR for TAAA.
Virtual reality (VR) provides an immersive image viewing experience that has recently been expanding in use in clinical medicine. We developed a three-dimensional (3D) model of an abdominal aortic aneurysm (AAA) for patients with a diagnosis of an AAA to view in VR to assess the utility of VR in patient education.
Migration of the iliac limb after endovascular abdominal aortic aneurysm repair (EVAR) can result in type 1b and 3 endoleaks that are relatively common causes of reintervention after EVAR. The aim of the present study was to investigate the factors influencing migration of the iliac limb and methods of treatment.
No consensus exists on the optimal strategy for treatment of abdominal aortic aneurysm (AAA) associated with colorectal cancer (CRC). The purpose of this study was to evaluate the results of endovascular treatment of AAA with simultaneous resection of CRC.
Abstract OBJECTIVE: To report the outcome of elective fenestrated and branch (FEVAR-BEVAR) endovascular aortic repair with supracoeliac (SC) sealing zones and the impact of staged repair without prophylactic cerebrospinal fluid (CSF) drainage on the incidence of spinal cord ischaemia (SCI). METHODS: Two hundred and seventy consecutive patients (217 men; mean [SD] age, 72.8 ± 6.3 years; median (IQR) diameter 65 mm [62-75 mm]) with juxtarenal (JRAAA) (n = 69) or thoraco-abdominal aortic aneurysms (TAAAs) (n = 201) underwent elective FEVAR (n = 192) or BEV...
In this issue, Antoniou et al. report on the prognostic role of low psoas muscle area (PMA) in overall survival of patients with asymptomatic abdominal aortic aneurysms (AAAs) undergoing open and endovascular aneurysm repair.1 Their meta-analysis of seven cohort studies concluded that patients with low PMA had a significant ly higher odds of mortality compared with patients with more PMA. Therefore, the authors postulate that PMA may be used as a prognostic tool in the pre-operative risk management and stratification of patients, even considering some of the methodological challenges identified in this review.
Ye Chean Teh1,2, Jeak Ling Ding2, Lai Guan Ng1,3,4 and Shu Zhen Chong1* 1Functional Immune Imaging, Singapore Immunology Network (SIgN), A*STAR (Agency for Science, Technology and Research), Biopolis, Singapore 2Department of Biological Sciences, National University of Singapore (NUS), Singapore, Singapore 3Department of Microbiology &Immunology, Immunology Programme, Life Science Institute, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore 4School of Biological Sciences, Nanyang Technological University, Singapore, Singapore Monocytes are a subset of cells that are ca...